Rare pancreatic ductal adenocarcinoma variants and other malignant epithelial tumors: a comprehensive clinical and radiologic review

罕见胰腺导管腺癌变异型及其他恶性上皮肿瘤:全面的临床和放射学综述

阅读:1

Abstract

Over 95% of pancreatic carcinomas are classified as conventional pancreatic ductal adenocarcinoma (cPDAC), while less than 5% consist of rare histological subtypes. Some of these rare histological subtypes, such as colloid carcinoma, medullary carcinoma, and undifferentiated carcinoma with osteoclast-like giant cells, are associated with a relatively better prognosis compared to cPDAC, whereas others, including signet ring cell carcinoma/poorly cohesive carcinoma, adenosquamous carcinoma, large cell carcinoma with rhabdoid phenotype, and undifferentiated carcinoma, have a worse prognosis. Other malignant pancreatic epithelial tumors (MPET) include acinar cell carcinoma, pancreatoblastoma, and solid-pseudopapillary neoplasm that should also be differentiate from PDACs. Accurate differentiation among PDAC subtypes and other MPETs is essential for precise survival predictions and effective therapeutic planning. However, cPDAC, rare histological subtypes of PDAC and MPETs often exhibit similar imaging findings, making it challenging to establish a diagnosis based solely on imaging. Thus, needle biopsy or surgical resection is generally required for the final diagnosis. We herein present a review article based on case studies and literature reviews of rare histological subtypes of PDAC and other MPET, with particular focus on their imaging characteristics, referencing the 5th edition of the World Health Organization classification.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。